Metropolitan Life Insurance Company (MetLife)’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-12,656
| Closed | -$119K | – | 2600 |
|
|
2020
Q3 | $119K | Hold |
12,656
| – | – | ﹤0.01% | 2115 |
|
|
2020
Q2 | $96.8K | Hold |
12,656
| – | – | ﹤0.01% | 2269 |
|
|
2020
Q1 | $78.2K | Hold |
12,656
| – | – | ﹤0.01% | 2185 |
|
|
2019
Q4 | $154K | Hold |
12,656
| – | – | ﹤0.01% | 2081 |
|
|
2019
Q3 | $146K | Hold |
12,656
| – | – | ﹤0.01% | 2089 |
|
|
2019
Q2 | $126K | Hold |
12,656
| – | – | ﹤0.01% | 2188 |
|
|
2019
Q1 | $163K | Hold |
12,656
| – | – | ﹤0.01% | 2040 |
|
|
2018
Q4 | $192K | Hold |
12,656
| – | – | ﹤0.01% | 1846 |
|
|
2018
Q3 | $253K | Hold |
12,656
| – | – | ﹤0.01% | 1849 |
|
|
2018
Q2 | $247K | Hold |
12,656
| – | – | ﹤0.01% | 1803 |
|
|
2018
Q1 | $255K | Hold |
12,656
| – | – | ﹤0.01% | 1739 |
|
|
2017
Q4 | $168K | Sell |
12,656
-11,484
| -48% | -$173K | ﹤0.01% | 2014 |
|
|
2017
Q3 | $445K | Hold |
24,140
| – | – | ﹤0.01% | 1768 |
|
|
2017
Q2 | $444K | Hold |
24,140
| – | – | ﹤0.01% | 1784 |
|
|
2017
Q1 | $544K | Hold |
24,140
| – | – | ﹤0.01% | 1594 |
|
|
2016
Q4 | $840K | Hold |
24,140
| – | – | 0.01% | 1393 |
|
|
2016
Q3 | $592K | Hold |
24,140
| – | – | ﹤0.01% | 1594 |
|
|
2016
Q2 | $577K | Hold |
24,140
| – | – | ﹤0.01% | 1599 |
|
|
2016
Q1 | $565K | Hold |
24,140
| – | – | ﹤0.01% | 1510 |
|
|
2015
Q4 | $729K | Hold |
24,140
| – | – | 0.01% | 1373 |
|
|
2015
Q3 | $959K | Buy |
24,140
+2,816
| +13% | +$175K | 0.01% | 1211 |
|
|
2015
Q2 | $1.47M | Buy |
21,324
+1,126
| +6% | +$70.8K | 0.01% | 1078 |
|
|
2015
Q1 | $1.1M | Buy |
20,198
+2,094
| +12% | +$99.8K | 0.01% | 1151 |
|
|
2014
Q4 | $772K | Buy |
18,104
+683
| +4% | +$24.7K | 0.01% | 1490 |
|
|
2014
Q3 | $556K | Sell |
17,421
-1,896
| -10% | -$40.4K | ﹤0.01% | 1656 |
|
|
2014
Q2 | $400K | Buy |
19,317
+260
| +1% | +$4.8K | ﹤0.01% | 1998 |
|
|
2014
Q1 | $369K | Sell |
19,057
-484
| -2% | -$10.3K | ﹤0.01% | 2013 |
|
|
2013
Q4 | $474K | Buy |
19,541
+361
| +2% | +$8.49K | ﹤0.01% | 1838 |
|
|
2013
Q3 | $412K | Hold |
19,180
| – | – | ﹤0.01% | 1891 |
|
|
2013
Q2 | $427K | Buy |
+19,180
| New | +$423K | ﹤0.01% | 1793 |
|
Metropolitan Life Insurance Company (MetLife)'s AMAG Position: Q4 2020 in Review
Metropolitan Life Insurance Company (MetLife) sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 12,656 shares — an estimated $119K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $1.47M in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Metropolitan Life Insurance Company (MetLife) reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 12,656 AMAG Pharmaceuticals shares in Q4 2020, an estimated $119K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- Metropolitan Life Insurance Company (MetLife)'s AMAG Pharmaceuticals position peaked at $1.47M in Q2 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2020, filed 16 Feb 2021.